Hussein Kanji
Annie Theriault
Orlando Serani
As of May 2018, Orlando leads the program strategy for the recently announced Chimeric Antigen Receptor T-Cells therapeutic area. This includes digital strategies, supply chain network design, and supply chain capability development for this therapy platform, currently targeted as a last line of defense for multiple myeloma.
Previously, Orlando was Vice President, Information Technology, Customer and Logistics Services: the logistics and customer services organization which serves all Johnson & Johnson businesses globally. Additionally, he also led the technology organization of the Consumer Medical Devices supply chain, including diabetes, contact lenses, and vision surgery products and services.
Orlando began his career with the Johnson & Johnson Consumer business in Italy in 1988. After a Foreign Service National assignment with the United States Information Agency in Rome, Italy from 1990 until 1992, he rejoined Johnson & Johnson’s Ortho-Clinical Diagnostics, where he held diverse positions in R&D, Sales and Marketing, and IT. In 2010, as part of the announcement of the Johnson & Johnson enterprise supply chain, he led the development of strategies to further establish and create new business services including safe and secure supply chain (i.e. anti-counterfeit, serialization, track and trace), enterprise-wide internal and external technology standards (enterprise master data, GS1, UDI, RFID), and new channel management strategies (ecommerce, demand sensing, distribution and transportation optimization).
Orlando holds a Bachelor of Science in Electrical Engineering from Rutgers University. He has been actively involved in several industry forums focused to the development and adoption of industry standards, including the development and adoption of the ISBT-128 transfusion medicine, including current membership in the US GS1 technical advisory group. He is a member of the program advisory board for the graduate supply chain program of Fairleigh Dickinson University, Silberman College of Business. He is an active speaker for the South Asian Professional Network Association (SAPNA) and Hispanic Organization for Leadership and Achievement (HOLA) enterprise groups, and a sponsor for the African American Leadership Council (AALC). He is active in his community, especially on activities focused on raising awareness of social and health issues.
David C. Rhew, MD
Dr. David C. Rhew is the Global Chief Medical Officer (CMO) and Vice-President (VP) of Healthcare for Microsoft. He is the Chairman of the Health and Fitness Technology Division for the Consumer Technology Association and serves on CTA’s Board of Industry Leaders. He co-holds six U.S. technology patents that enable authoring, mapping, and integration of clinical decision support into the electronic health record. David is currently an Adjunct Professor at the Stanford University School of Medicine.
Dr. Rhew received his Bachelors of Science degrees in computer science and cellular molecular biology from the University of Michigan. He received his MD degree from Northwestern University and completed internal medicine residency at Cedars-Sinai Medical Center. He completed fellowships in health services research at Cedars-Sinai and infectious diseases at the University of California, Los Angeles.
He has served as CMO and VP for Samsung; Senior Vice-President and CMO at Zynx Health Incorporated; clinician/researcher in the Division of Infectious Diseases at the VA Greater Los Angeles Healthcare System; and Associate Clinical Professor of Medicine at UCLA. Dr. Rhew has served on the National Quality Forum’s (NQF) Executive Committee for Consensus Standards and Approval.
Mitzi Krockover
Jana Bobosikova
Dr. Renee Whynes
Dr. Renee Whynes holds a Doctorate degree in Biophysical Chemistry, with a Bachelor of Science degree in Chemistry. She also holds a MBA with a concentration in Supply Chain Management and Marketing. Dr. Whynes has more than 12 years of progressively responsible experience directing many projects with budgets. Her experience includes finding innovative solutions in skin care and wet shaving; external partnership development with universities and other research organizations; technology scouting; new product development; new business development; assessment of near to long-term market opportunities; and identification of market disruptors.
Dr. Catja Prykop
Dr. Catja Prykop is Global Marketing Director with a strong passion for Personalization. Over the past 11 years at Beiersdorf, she contributed to building brands like NIVEA, Hansaplast and Eucerin, having been responsible for a strong insight-based innovation pipeline and global brand strategy development particularly for Face Care and Face Cleansing. Catja is a senior business leader, global marketeer and strategist, recognized for consumer closeness. Experienced in Cosmetics, Media and Finance, personalized consumer engagement is at her heart. Catja holds a PhD in economics. Together with Dr. Frank Schwanke, she is heading the Personalization Accelerator.